| Category: |
Antibody |
| Concentration: |
pH7, with 0, 02% sodium azide, 3, 5 mg/ml in 1X TBS, 5% BSA (US sourced) and 0 |
| Form: |
Antigen affinity purified |
| Conjugation: |
Unconjugated |
| Clone: |
Polyclonal antibody |
| Recognised antigen: |
ADRA1B |
| Host animal: |
Goat (Capra aegagrus hircus) |
| Clonality: |
Polyclonal (goat origin) |
| Species reactivity: |
Due to limited knowledge and inability to test the antibody against all known species, we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens) |
| Tested applications: |
ELISA (peptide), WB |
| Recommended dilutions: |
3-1ug/ml, ELISA (peptide) LOD: 1:128000, Western blot: 0 |
| Notes: |
Optimal dilution of the ADRA1B antibody should be determined by the researcher |
| Intented use: |
This ADRA1B antibodyis to be used only for research purposes and not for diagnostics |
| Gene ID #: |
147 |
| Purity: |
Antigen affinity |
| Description: |
Additional name(s) for this target protein: Alpha-1B-adrenergic receptor |
| Immunogen: |
Amino acids TLRIHSKNFHEDT were used as the immunogen for this ADRA1B antibody |
| Storage: |
Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, Aliquot and store the ADRA1B antibody at -20 deg |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24° |
| Gene target: |
ADRA1B |
| Short name: |
ADRA1B Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
adrenoceptor a 1B (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
ADRA1 and ALPHA1BAR, ADRA1B and IDBG-55923 and ENSG00000170214 and 147, Adra1b and IDBG-164464 and ENSMUSG00000050541 and 11548, BT, nuclei, protein heterodimerization activity, this GO :0001974 and blood vessel remodeling and biological process this GO :0001975 and response to amphetamine and biological process this GO :0001987 and vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure and biological process this GO :0001996 and positive regulation of heart rate by epinephrine-norepinephrine and biological process this GO :0001997 and positive regulation of the force of heart contraction by epinephrine-norepinephrine and biological process this GO :0004930 and G-protein coupled receptor activity and molecular function this GO :0004937 and alpha1-adrenergic receptor activity and molecular function this GO :0005634 and nucleus and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0007188 and adenylate cyclase-modulating G-protein coupled receptor signaling pathway and biological process this GO :0007267 and cell-cell signaling and biological process this GO :0007275 and multicellular organismal development and biological process this GO :0007512 and adult heart development and biological process this GO :0007626 and locomotory behavior and biological process this GO :0008283 and cell proliferation and biological process this GO :0008542 and visual learning and biological process this GO :0016021 and integral component of membrane and cellular component this GO :0016049 and cell growth and biological process this GO :0019229 and regulation of vasoconstriction and biological process this GO :0031965 and nuclear membrane and cellular component this GO :0035265 and organ growth and biological process this GO :0035556 and intracellular signal transduction and biological process this GO :0042593 and glucose homeostasis and biological process this GO :0043278 and response to morphine and biological process this GO :0043410 and positive regulation of MAPK cascade and biological process this GO :0045818 and negative regulation of glycogen catabolic process and biological process this GO :0045819 and positive regulation of glycogen catabolic process and biological process this GO :0046982 and protein heterodimerization activity and molecular function this GO :0048148 and behavioral response to cocaine and biological process this GO :0055117 and regulation of cardiac muscle contraction and biological process this GO :0071875 and adrenergic receptor signaling pathway and biological process, this GO :0004930 : G-protein coupled receptor activity, this GO :0004930 : G-protein coupled receptor activity and also this GO :0004937 : alpha1-adrenergic receptor activity and also this GO :0046982 : protein heterodimerization activity, this GO :0004937 : alpha1-adrenergic receptor activity, this GO :0046982 : protein heterodimerization activity, 27996 and IDBG-646421 and ENSBTAG00000040253 and 407140, adrenoceptor alpha 1B |
| Identity: |
278 |
| Gene: |
ADRA1B |
More about : ADRA1B |
| Long gene name: |
adrenoceptor alpha 1B |
| Synonyms gene name: |
adrenergic, alpha-1B-, receptor |
| Locus: |
5q33, 3 |
| Discovery year: |
1991-06-04 |
| GenBank acession: |
L31773 |
| Entrez gene record: |
147 |
| Classification: |
Adrenoceptors |
| Havana BLAST/BLAT: |
OTTHUMG00000130327 |